ARCHIVES

Avon, four companies Fund NABCO Patient Information Services

This article is from The Cancer Letter archive.

Vol. 20 No. 04 | January 28, 1994

Download PDF Visit The Full Archive

Related Articles

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

May 9, 2014

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

March 2, 2001

Cancer Patients Who Die In Hospital Or ICU Have Worse QOL; Caregivers Affected, Too

September 24, 2010

Scientists Brief Writers On Progress In Cancer Research

April 11, 1975

NCI Programs: Contract Awarded For Geographic Information System

May 14, 1999

ASCO Lists Top 11 Advances In Clinical Cancer Research

December 30, 2005